Pacira BioSciences, Inc.
PCRX· Nasdaq
Released Nov 2, 2016, during market hours
10-Q filed Nov 2, 2016, 33 days after period end · 0001396814-16-000028
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $68.36M | $62.21M | $52.05M | $23.26M |
| Net Income | -$22.16M | $3.09M | -$3.00M | -$14.78M |
| EPS Diluted | -$0.59 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| $0.08 |
| -$0.08 |
| -$0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.